1.36

0.00% 0.005

Vivani Medical Inc (VANI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.355

Offen:

$1.36

24-Stunden-Volumen:

126.98K

Relative Volume:

0.28

Marktkapitalisierung:

$122.23M

Einnahmen:

Nettoeinkommen (Verlust:

$-27.09M

KGV:

-3.3697

EPS:

-0.4036

Netto-Cashflow:

$-26.52M

1W Leistung:

-4.58%

1M Leistung:

-3.90%

6M Leistung:

+15.81%

1J Leistung:

+5.86%

1-Tages-Spanne:

$1.325

$1.36

1-Wochen-Bereich:

$1.325

$1.515

52-Wochen-Spanne:

$0.9228

$1.92

Vivani Medical Inc Stock (VANI) Company Profile

Firmenname

Vivani Medical Inc

Sektor

Healthcare (1087)

Branche

Biotechnology (606)

Telefon

415-506-8462

Adresse

1350 S. LOOP ROAD, ALAMEDA

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-12

Neueste SEC-Einreichungen

VANI's Discussions on Twitter

Compare VANI vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VANI Vivani Medical Inc	1.355	122.23M	0	-27.09M	-26.52M	-0.4036
VRTX Vertex Pharmaceuticals Inc	522.51	134.06B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	801.48	83.43B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,002.19	63.00B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	138.48	56.02B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.62	44.44B	742.00K	-1.37B	-1.07B	-7.0731

Vivani Medical Inc Aktie (VANI) Neueste Nachrichten

02:24 AM

Vivani Medical (NASDAQ:VANI) Trading Down 9.1%Here's What Happened - MarketBeat

02:24 AM

Sep 06, 2026

Maxim Group Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $4 - Moomoo

Sep 06, 2026

Sep 03, 2026

Vivani Medical to Participate in Upcoming Lake Street and H.C. Wainwright Investor Conferences - Quiver Quantitative

Sep 03, 2026

Two New York conferences are planned for Vivani Medical - Stock Titan

Sep 03, 2026

Vivani Medical Announces Participation in Upcoming Investor Conferences - GlobeNewswire

Sep 03, 2026

Aug 21, 2026

VANI Stock Price, Quote & Chart - ChartMill

Aug 21, 2026

Aug 18, 2026

Vivani (VANI) Quarter in Review: EPS Lands Above Forecast in the Latest Session; Trading Response - Vinanet

Aug 18, 2026

Aug 17, 2026

Form 8K Vivani Medical Inc For: 17 August By Investing.com - Investing.com Nigeria

Aug 17, 2026

Vivani Medical posts slide presentation under Reg FD; Exhibit 99.1 attached - TradingView

Aug 17, 2026

Vivani Medical posts investor deck outlining NanoPortal ultra-long-acting GLP-1 implant strategy for obesity market - Bitget

Aug 17, 2026

Aug 15, 2026

Wall Street Zen Upgrades Vivani Medical (NASDAQ:VANI) to "Hold" - MarketBeat

Aug 15, 2026

Aug 14, 2026

Vivani Medical (NASDAQ: VANI) Completes Full Enrollment In Semaglutide Implant Trial, Strikes Novo Nordisk Deal - foreignpolicyjournal.com

Aug 14, 2026

VANI Q1 2026 Earnings: Narrower Loss Slightly Beats Consensus, Shares Rise 4.48%Balance Sheet Strength - vinanet.vn

Aug 14, 2026

Vivani Medical Fully Enrolls Phase 1 Semaglutide Implant Trial; Data Due November - Minichart

Aug 14, 2026

Aug 13, 2026

Form 8K Vivani Medical Inc For: 13 August By Investing.com - Investing.com Nigeria

Aug 13, 2026

Vivani Medical (NASDAQ:VANI) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Aug 13, 2026

Vivani Medical Q2 losses narrow 41% YoY; signs Novo Nordisk deal - scanx.trade

Aug 13, 2026

Vivani Medical: Q2 Earnings Snapshot - Barchart.com

Aug 13, 2026

Vivani Medical Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 13, 2026

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update - Yahoo Finance

Aug 13, 2026

Vivani Medical (VANI) widens GLP‑1 pipeline, funds runway into Q2 2027 - Stock Titan

Aug 13, 2026

Aug 11, 2026

ClearOne (CLRO) details Cortigent reverse merger, 78% Vivani control and new equity plan - Stock Titan

Aug 11, 2026

ClearOne to merge with Cortigent, pivoting to neurotech under new Nasdaq ticker - Dealroom

Aug 11, 2026

Aug 07, 2026

Vivani Medical Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Aug 07, 2026

Aug 06, 2026

ClearOne Inc. (CLRO) majority holder cancels warrant as Cortigent merger proceeds - Stock Titan

Aug 06, 2026

Form 8K Vivani Medical Inc For: 6 August By Investing.com - Investing.com Nigeria

Aug 06, 2026

Vivani Medical Completes Enrollment, Dosing in Phase 1 SLIM-1 Trial - marketscreener.com

Aug 06, 2026

Vivani Completes Enrollment in SLIM-1 Semaglutide Implant Trial - TipRanks

Aug 06, 2026

Form 8K Vivani Medical Inc For: 6 August - Investing.com India

Aug 06, 2026

Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management - The Manila Times

Aug 06, 2026

Semaglutide implant trial doses all 20 participants; data expected in November - Stock Titan

Aug 06, 2026

Aug 05, 2026

ClearOne Cancels 437,500 First Finance Warrants at $5.00 Amid Cortigent Merger Process - TradingView

Aug 05, 2026

Vivani Medical (VANI) to Announce Earnings on Wednesday - MarketBeat

Aug 05, 2026

Aug 02, 2026

Vivani Medical (VANI) Dips 1.54% to $1.28, Holding Within Key $1.22 Support and $1.34 Resistance RangePassive Flow - vinanet.vn

Aug 02, 2026

Aug 01, 2026

Enterprise value to EBITDA forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView

Aug 01, 2026

Vivani Medical (NASDAQ: VANI) grants COO options and performance RSUs - Stock Titan

Jul 30, 2026

Jul 29, 2026

Form 4 Vivani Medical Inc For: 28 July - Investing.com India

Jul 29, 2026

Jul 28, 2026

Form 4 Vivani Medical Inc For: 28 July By Investing.com - Investing.com Canada

Jul 28, 2026